Chemical activators of LOC389493 utilize various cellular signaling pathways to modulate the phosphorylation status and thereby the activity of this protein. Okadaic Acid, for instance, serves as a robust inhibitor of protein phosphatases 1 and 2A, thus preventing dephosphorylation and maintaining LOC389493 in an active state. Similarly, Calyculin A operates through the inhibition of the same phosphatases, ensuring that LOC389493 remains phosphorylated and active. Phorbol 12-myristate 13-acetate (PMA) and Bryostatin 1, both activators of protein kinase C (PKC), augment the phosphorylation of LOC389493 through PKC-mediated signaling pathways. Oleoyl-2-acetyl-sn-glycerol (OAG), a synthetic analog of diacylglycerol, also activates PKC, which in turn can lead to LOC389493 activation through phosphorylation.
Further contributing to the activation of LOC389493, Forskolin increases intracellular cAMP levels, thereby activating protein kinase A (PKA), which can phosphorylate LOC389493. Dibutyryl-cAMP (db-cAMP), a cell-permeable analog of cAMP, similarly activates PKA leading to the activation of LOC389493. Ionomycin, by acting as a calcium ionophore, raises intracellular calcium levels that activate calmodulin-dependent kinases capable of phosphorylating and activating LOC389493. Thapsigargin, by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), results in increased cytosolic calcium which can also lead to the activation of LOC389493 through calcium-dependent protein kinases. Anisomycin, although primarily a protein synthesis inhibitor, can activate stress-activated protein kinases such as JNK, which then may phosphorylate LOC389493. Lastly, Endothelin-1, through its action on the endothelin receptor, activates downstream kinases including PKC, which can again result in the phosphorylation and activation of LOC389493, while Ouabain indirectly affects the phosphorylation state of LOC389493 through modulation of ion gradients and signal transduction pathways.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which when inhibited, can lead to increased phosphorylation levels of various proteins. Since LOC389493 activity is regulated by its phosphorylation status, inhibition of PP1 and PP2A by okadaic acid can result in the sustained activation of LOC389493. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). When PKC is activated, it can phosphorylate a multitude of proteins. Since LOC389493 can be phosphorylated by PKC as part of its activation process, PMA can thus lead to the activation of LOC389493. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, increasing intracellular calcium concentrations. Elevated calcium can activate calmodulin-dependent kinases, which in turn can phosphorylate and activate LOC389493. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels. This rise in calcium can activate calcium-dependent protein kinases that phosphorylate and activate LOC389493. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 binds to and activates protein kinase C (PKC). PKC activation results in the phosphorylation of several substrates, including LOC389493, leading to its activation. | ||||||
1-Oleoyl-2-acetyl-sn-glycerol (OAG) | 86390-77-4 | sc-200417 sc-200417A | 10 mg 50 mg | $119.00 $453.00 | 1 | |
OAG is a synthetic analog of diacylglycerol (DAG) and serves as an activator of protein kinase C (PKC). By activating PKC, OAG can promote the phosphorylation and subsequent activation of LOC389493. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation of proteins. By inhibiting the dephosphorylation, calyculin A can cause the activation of LOC389493 through sustained phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor which also activates stress-activated protein kinases (SAPKs) like JNK. Activation of these kinases can lead to phosphorylation and activation of LOC389493. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates protein kinase A (PKA). Activation of PKA can lead to the phosphorylation and subsequent activation of LOC389493. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits the Na+/K+ ATPase pump, leading to alterations in ion gradients that can activate signal transduction pathways involving sodium/calcium exchangers and potentially lead to the activation of kinases that phosphorylate LOC389493. | ||||||